4-IBP

CAS No. 155798-08-6

4-IBP( —— )

Catalog No. M18082 CAS No. 155798-08-6

4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 30 In Stock
25MG 64 In Stock
50MG 110 In Stock
100MG 161 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-IBP
  • Note
    Research use only, not for human use.
  • Brief Description
    4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
  • Description
    4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    σ1|σ2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    155798-08-6
  • Formula Weight
    420.29
  • Molecular Formula
    C19H21IN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 20 mg/mL 47.59 mM;H2O : < 0.1 mg/mL
  • SMILES
    Ic1ccc(cc1)C(=O)NC3CCN(Cc2ccccc2)CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Linzagolix choline

    Linzagolix choline is an orally available non-peptide gonadotropin-releasing hormone (GnRH) antagonist. It can be used to study pain associated with uterine fibroids and endometriosis.

  • SGC-CBP30

    SGC-CBP30 is an effective CREBBP/EP300 inhibitor (IC50: 21/38 nM).

  • Niraparib Tosylate M...

    Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.